|
1
|
Peroxisome proliferator-activated receptor targets for the treatment of metabolic diseases.
|
Mediators Inflamm
|
2013
|
1.27
|
|
2
|
Cancer cachexia: the molecular mechanisms.
|
Int J Biochem Cell Biol
|
2003
|
1.18
|
|
3
|
Anticachectic effects of formoterol: a drug for potential treatment of muscle wasting.
|
Cancer Res
|
2004
|
1.15
|
|
4
|
Impact on fatty acid metabolism and differential localization of FATP1 and FAT/CD36 proteins delivered in cultured human muscle cells.
|
Am J Physiol Cell Physiol
|
2005
|
1.13
|
|
5
|
Elevated concentration of asymmetric dimethylarginine (ADMA) in individuals with metabolic syndrome.
|
Nitric Oxide
|
2011
|
0.96
|
|
6
|
Apoptosis is present in skeletal muscle of cachectic gastro-intestinal cancer patients.
|
Clin Nutr
|
2007
|
0.96
|
|
7
|
Antiplatelet, anticoagulant, and fibrinolytic activity in vitro of extracts from selected fruits and vegetables.
|
Blood Coagul Fibrinolysis
|
2011
|
0.95
|
|
8
|
Hemostasis alterations in metabolic syndrome (review).
|
Int J Mol Med
|
2006
|
0.95
|
|
9
|
Fractions of aqueous and methanolic extracts from tomato (Solanum lycopersicum L.) present platelet antiaggregant activity.
|
Blood Coagul Fibrinolysis
|
2012
|
0.91
|
|
10
|
Evaluation of metabolic syndrome in adults of Talca city, Chile.
|
Nutr J
|
2008
|
0.87
|
|
11
|
Role of PPARs in inflammatory processes associated with metabolic syndrome (Review).
|
Mol Med Rep
|
2013
|
0.84
|
|
12
|
Prevalence of heparin-induced antibodies in patients with chronic renal failure undergoing hemodialysis.
|
J Clin Lab Anal
|
2005
|
0.84
|
|
13
|
Intervention with education and exercise reverses the metabolic syndrome in adults.
|
J Am Soc Hypertens
|
2010
|
0.84
|
|
14
|
Catabolic mediators as targets for cancer cachexia.
|
Drug Discov Today
|
2003
|
0.81
|
|
15
|
Gene expression of adipose tissue, endothelial cells and platelets in subjects with metabolic syndrome (Review).
|
Mol Med Rep
|
2012
|
0.80
|
|
16
|
Pathophysiology of the proatherothrombotic state in the metabolic syndrome.
|
Front Biosci (Schol Ed)
|
2010
|
0.80
|
|
17
|
Increased concentrations of soluble vascular cell adhesion molecule-1 and soluble CD40L in subjects with metabolic syndrome.
|
Mol Med Rep
|
2011
|
0.79
|
|
18
|
Targets in clinical oncology: the metabolic environment of the patient.
|
Front Biosci
|
2007
|
0.77
|
|
19
|
The systemic inflammatory response is involved in the regulation of K(+) channel expression in brain via TNF-alpha-dependent and -independent pathways.
|
FEBS Lett
|
2004
|
0.77
|
|
20
|
Increased concentration of plasminogen activator inhibitor-1 and fibrinogen in individuals with metabolic syndrome.
|
Mol Med Rep
|
2011
|
0.77
|
|
21
|
Effect of tomato industrial processing (different hybrids, paste, and pomace) on inhibition of platelet function in vitro, ex vivo, and in vivo.
|
J Med Food
|
2013
|
0.75
|
|
22
|
High levels of hsCRP are associated with carbohydrate metabolism disorder.
|
J Clin Lab Anal
|
2011
|
0.75
|